
A survey finds that delay-related harm fell sharply. Strong trust in AI also collapsed, and clinicians now want strict limits and human oversight.
A discussion on optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.




